稳定慢性阻塞性肺病患者的甲氨酸脱酶 - 初步结果
Elżbieta Małujło-Balcerska1,2, Anna Kumor-Kisielewska3, Maria Gałecka4
1Department of Pneumonology, Medical University of Łódź, Łódź, Poland. elzbieta.malujlo-balcerska@umed.lodz.pl.
Pharmacological reports : PR
|June 19, 2025
概括
甲状腺激素二氧化酶 (DIO) 和促炎细胞因子在慢性阻塞性肺病 (COPD) 中升高. 这些分子与COPD风险存在关联,这表明它们在疾病机制中起作用.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 肺部病理学 肺部病理学
背景情况:
- 免疫/炎症分子在COPD等炎症性疾病中至关重要.
- 甲状腺激素 (THs) 和它们通过铁二氧化酶 (DIO) 的代谢与免疫/炎症反应有关.
- 细胞因子可能会影响TH代谢相关的因素,这表明与COPD有联系.
研究的目的:
- 在稳定的COPD患者中研究DIO酶和益炎性细胞因子的水平.
- 探索COPD患者的DIO,细胞因子和临床数据之间的相关性.
- 了解免疫内分泌相互作用在COPD病变发生中的潜在作用.
主要方法:
- 一项涉及55名参与者的横截面研究 (25名稳定的COPD患者,30名对照).
- 使用ELISA套件测量DIO (DIO1-3) 和细胞因子 (IL-1β,IL-6,TNF-ɑ,IFN-ɣ) 的水平.
- 相关性分析用于评估蛋白质水平,临床数据和COPD风险之间的关系.
主要成果:
- 在COPD患者中观察到高水平的DIO1-3和益炎性细胞因子 (IL-1β,IL-6,TNF-ɑ,IFN-ɣ).
- 在DIO和细胞因子水平之间发现了显著的相关性,特别是DIO2和IFN-ɣ.
- 较高的DIO和细胞因子水平与COPD相对风险和临床数据有关.
结论:
- DIO酶和促炎性细胞因子可能参与COPD的机制.
- 这些发现表明,在COPD中,免疫内分泌相互作用可能起作用.
- 建议对更大的队列和受控因素进行进一步的研究,以进行精确的监测和治疗评估.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
329
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
329
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K